Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Tumor Cell Vaccines and ISCOMATRIX With Chemotherapy After Tumor Removal

This study has been terminated.
Sponsor:
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Cancer Institute (NCI) )
ClinicalTrials.gov Identifier:
NCT01341496
First received: April 22, 2011
Last updated: August 6, 2016
Last verified: July 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: July 2016
  Primary Completion Date: May 2016 (Final data collection date for primary outcome measure)